Drug Index

Prochlorperazine

 
print

Mechanism :

Prochlorperazine is a phenothiazine derivative. It is used as an anti-emetic agent that acts by blocking the dopamine receptors.


Indication :

• Chemotherapy, radiotherapy induced vomiting

• Intractable vomiting

• Psychotic disorder


Contraindications :

Do not use in patients with known hypersensitivity to phenothiazines Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.), in pediatric surgery, or in pediatric patients under 2 years of age or under 20 lbs. Do not use in children for conditions for which dosage has not been established.


Dosing :

<2 years: Not recommended.

Severe Nausea and Vomiting:

≥2 years:

9-13 kg: 2.5 mg PO daily or 12 hourly; Maximum dose: 7.5 mg/day.

14-18 kg: 2.5 mg PO every 8-12 hours; Maximum dose: 10 mg/day.

19-37 kg: 2.5 mg PO 8 hourly or 5 mg PO every 12 hours; Maximum dose: 15 mg/day.

Psychotic disorder:

>2 years: Initially 2.5 mg PO/PR every 8-12 hours.

Maximum dose: 20 mg/day in 2-6 years and 25 mg/day in 6-12 years; do not exceed 10 mg on day 1.


Adverse Effect :

Excitation, weakness, cerebral edema, poikilothermia, ECG changes, tachycardia, agitation, dry mouth, nasal stuffiness and insomnia. Extrapyramidal symptoms may occur. Rarely neuroleptic malignant syndrome may occur. In susceptible patients, respiratory depression may occur. Postural hypotension has also been reported.


Interaction :

Metoclopramide and Lithium: Increased extrapyramidal side-effects with metoclopramide and lithium.
Antiepileptics: Decreased effect of antiepileptics.
Antacids: Decreased levels with antacids.
Anxiolytics and Hypnotics: Enhanced sedative effects with anxiolytics and hypnotics.
Deferoxamine: Avoid with deferoxamine.



Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Start with small doses, i.e. 6.25 mg IM or 5 mg orally

Dose in Patients undergoing Renal Replacement Therapies
CAPDUnlikely to be dialysed. Dose as in GFR<10 mL/min
HDUnlikely to be dialysed. Dose as in GFR<10 mL/min
HDF/High fluxUnknown dialysability. Dose as in GFR<10 mL/min
CAV/VVHDUnlikely to be dialysed. Dose as in normal renal function

Hepatic Dose :

Dose adjustment guidelines are not available. Dose adjustment may be required due to high hepatic metabolism. Hepatic impairment will increase exposure to drug, reduction of dose is reasonable.
08/05/2020 08:27:59 Prochlorperazine
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0